AVTR
Avantor, Inc.
Key Financials
Gross Profit
$2.1B
↓ 6.1%
Net Income
$-530200000
↓ 174.5%
EPS (Diluted)
$-0.78
↓ 175.0%
Revenue
$6.6B
↓ 3.4%
Total Assets
$11.8B
↓ 2.6%
Total Liabilities
$6.2B
↑ 1.2%
Cash & Equivalents
$365.4M
↑ 39.5%
Shareholders' Equity
$5.6B
↓ 6.6%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 5/12/2026 | View on SEC |
| 4 | 5/11/2026 | View on SEC |
| 4 | 5/11/2026 | View on SEC |
| 4 | 5/11/2026 | View on SEC |
| 4 | 5/11/2026 | View on SEC |
| 4 | 5/11/2026 | View on SEC |
| 4 | 5/11/2026 | View on SEC |
| 4 | 5/11/2026 | View on SEC |
| 4 | 5/11/2026 | View on SEC |
| 4 | 5/5/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | AVTR |
| Company Name | Avantor, Inc. |
| CIK | 1722482 |
| Sector | Laboratory Analytical Instruments |
| Industry | Large accelerated filer |
| Exchange | NYSE |
| SIC Code | 3826 |
| SIC Description | Laboratory Analytical Instruments |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| Phone | (610) 386-1700 |